Ellume USA LLC

Part of Ellume PTY LTD

UEI
LC8WE4G8U773
CAGE
8J0W1
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
ellume.com
Founded
2010
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$3,050,000
FY2024 -$3,500,000

Contract awards

Similar vendors

About the company

Ellume USA LLC is a subsidiary of the Australian company Ellume PTY LTD, which is a foreign-owned, for-profit organization that develops and commercializes digital diagnostic products for clinicians and consumers. Ellume USA LLC is registered as a foreign-owned, self-certified small disadvantaged business in the System for Award Management (SAM).

Ellume USA LLC has been awarded prime federal contracts for COVID-19 diagnostic testing solutions. In September 2020, the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded Ellume a $29,950,000 firm-fixed-price contract for the development of a point-of-care COVID-19 antigen test for the direct detection of the SARS-CoV-2 virus. This contract has a completion date of March 29, 2023, and does not have a set-aside designation.

Ellume USA LLC does not appear to have been directly awarded any prime federal grant funding. However, the entity has received a sub-grant award from Emory University to participate in the Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) program.

In February 2021, the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Ellume USA LLC an Other Transaction (OT) Indefinite Delivery Vehicle (IDV) with a potential value of $283,858,070.93. This OT agreement, which is not subject to the Federal Acquisition Regulation (FAR), was awarded for the procurement of COVID-19 diagnostic testing prototypes. As an OT IDV, it provides the government with increased flexibility to rapidly acquire innovative technologies from Ellume USA LLC to support the national response to the COVID-19 pandemic.

Quick answers

Is Ellume USA LLC registered in SAM.gov?

Ellume USA LLC's SAM.gov registration expired on March 28, 2024.

What is Ellume USA LLC's CAGE code?

Ellume USA LLC's CAGE code is 8J0W1, and its Unique Entity ID (UEI) is LC8WE4G8U773.

What is Ellume USA LLC's most recent federal award?

Ellume USA LLC's most recent federal contract award is Radx-tech - ellume USA, LLC point-of-care covid-19 antigen test for the direct detection of the sars COV-2 virus (75N92020C00034), from National Heart Lung and Blood Institute (NIH), on September 30, 2020.

On GovTribe

See Ellume USA LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe